Semaglutide (Wegovy®) for Weight Loss — Online in Texas
Wegovy® and Ozempic® — prescribed by Dr. Dean or Dr. Kline after a real physician consultation. Not an algorithm. Not a chatbot. Your doctor.
Quick Answer
What is semaglutide and how do I get it in Texas?
Semaglutide is a once-weekly injectable GLP-1 receptor agonist (the active ingredient in Wegovy® and Ozempic®) FDA-approved for chronic weight management and type 2 diabetes. Trinity Family Medicine prescribes semaglutide via telehealth to eligible adults located in Texas after a video visit with a board-certified physician, with medication shipped from a licensed pharmacy directly to your home. Bundled plans start at $129/month including medication and visits.
- FDA-approved for chronic weight management at BMI ≥30, or ≥27 with a weight-related condition
- Average weight loss of ~15% over 68 weeks in the STEP 1 trial (NEJM, 2021)
- $129/month bundle (medication + physician visits) or $74.99 visit-only
- Carries an FDA Boxed Warning — not for patients with personal/family history of MTC or MEN 2
- Gradual dose titration starting at 0.25 mg weekly to minimize side effects
- Same physician manages titration and ongoing monitoring
What Is Semaglutide?
The science behind the most-prescribed GLP-1 weight loss medication.
Semaglutide is a GLP-1 receptor agonist — an injectable medication that mimics the naturally occurring gut hormone glucagon-like peptide-1. It is the active ingredient in both Wegovy® (FDA-approved for chronic weight management) and Ozempic® (FDA-approved for Type 2 diabetes).
In the landmark STEP clinical trials, patients taking semaglutide lost an average of 15% of their body weight over 68 weeks — significantly more than diet and exercise alone. For a 250-pound patient, that translates to roughly 37 pounds.
Semaglutide is administered as a once-weekly subcutaneous injection using a simple pen device. Your physician starts you at a low dose and gradually increases it over several months to minimize side effects and optimize results.
Reduces Appetite
Signals your brain to feel full sooner
Slows Digestion
Delays gastric emptying for lasting satiety
Blood Sugar Control
Stabilizes insulin and glucose response
Sustained Loss
Consistent, progressive weight reduction
Why Trinity Is Different
Real physicians. Real relationships. A practice built for patients, not shareholders.
Your Doctor, Every Time
No rotating providers. No chatbot prescriptions. Dr. Dean and Dr. Kline personally manage every patient's care — building a real relationship so your treatment evolves with you.
Physician-Owned, Not Venture Capitalist Backed
Trinity isn't a tech startup optimizing for investor returns. It's a medical practice built by doctors who believe weight loss deserves real medicine, not algorithms.
DPC Model = More Time With You
Direct Primary Care means no insurance red tape, longer visits, and a doctor who actually knows your chart. You're a patient here — not a number.
Semaglutide Dosing Schedule
A gradual titration schedule minimizes side effects and optimizes results.
Weeks 1–4
0.25 mgInitial dose — body adjusts to medication
Weeks 5–8
0.5 mgFirst increase — appetite suppression begins
Weeks 9–12
1.0 mgTherapeutic range — significant results
Weeks 13–16
1.7 mgEscalation if clinically appropriate
Week 17+
2.4 mgTarget maintenance dose for weight loss
Note from your physicians: This schedule is a general guideline based on FDA labeling. Dr. Dean and Dr. Kline personalize your dosing based on your response, side effects, and progress. Not every patient reaches 2.4 mg — and that's perfectly normal. Your physician adjusts the plan to what works best for you.
Semaglutide Side Effects
Transparent information so you can make an informed decision.
Important Safety Information: GLP-1 medications may cause serious side effects including risk of thyroid C-cell tumors. Do not use semaglutide if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Rare but serious side effects include pancreatitis, gallbladder problems, kidney injury, and severe allergic reactions. Dr. Dean and Dr. Kline monitor you closely throughout treatment and are available between visits for any concerns.
FDA & Compounded Semaglutide — What You Should Know (2026)
The FDA officially resolved the GLP-1 shortage in February 2025. Since then, large-scale compounding of semaglutide has been significantly restricted. At Trinity, we prioritize FDA-approved brand-name Wegovy® / Ozempic® when clinically appropriate and accessible. Compounded alternatives are only used in specific clinical circumstances (such as documented allergies to brand fillers or inability to tolerate a commercial dose), and only through licensed, accredited (PCAB / NABP) compounding pharmacies that can produce a Certificate of Analysis on request.
Be cautious of medspas or websites offering "cheap" semaglutide without a licensed prescribing physician, lab oversight, or pharmacy verification — these are the patient-safety red flags the FDA and Texas State Board of Pharmacy have repeatedly warned about.
Transparent Pricing
No hidden fees. No surprise bills.
Monthly Subscription
Save money with an all-inclusive plan — medication and physician visits bundled together.
- Medication included & shipped to your door
- Visit fees waived — $0 for every consultation
- Same physician, same personalized care
- Cancel anytime — no long-term contracts
Initial Consultation
Your first visit with Dr. Dean or Dr. Kline
- Comprehensive video visit
- Full health assessment & history review
- Personalized treatment plan
- Medication selection & dosing
- Nutrition guidance
3-Month Follow-Up
Ongoing care every 3 months
- Progress check-in visit
- Dose adjustment as needed
- Side effect management
- Updated treatment plan
- Direct physician access between visits
Medication Cost
Separate from visit fees
- Brand-name: market pricing
- Compounded: significantly lower cost
- Ships directly to your door
- Licensed, accredited pharmacies
- Your physician helps find the best option
Medicare $50 GLP-1 Program Available
Starting July 2026, eligible Medicare Part D enrollees can get Wegovy, Zepbound, or Foundayo for just $50 per month through the Medicare GLP-1 Bridge program. Qualification is based on BMI and health history — BMI 35+ qualifies automatically; BMI 30+ with heart failure, uncontrolled high blood pressure, or chronic kidney disease; or BMI 27+ with prediabetes or history of heart attack, stroke, or peripheral artery disease. If you already receive a GLP-1 through Medicare for diabetes, sleep apnea, or fatty liver disease, you do not qualify.
Learn more about qualifications and how to applyAm I Eligible?
Answer a few quick questions to see if GLP-1 treatment may be right for you.
Semaglutide FAQ
Physician-written answers about semaglutide treatment at Trinity.
Meet Your Physicians
Two board-certified physicians. One patient-centered practice.
Casey Dean, DO
Board-Certified Family Medicine Physician
Dr. Dean is a board-certified family medicine physician and co-founder of Trinity Family Medicine. With specialized expertise in metabolic restoration, he takes a patient-first approach to weight management — treating obesity as the complex metabolic condition it is, not a willpower problem.
- Board-Certified, Family Medicine
- TMB License #T3065
- NPI: 1134744824
Kathryn Kline, MD
Board-Certified Family Medicine Physician
Dr. Kline is a board-certified family medicine physician and co-founder of Trinity Family Medicine. Her background in metabolic strategy and women's health brings a thoughtful, holistic perspective to weight loss care — combining medication with nutrition guidance and ongoing physician support.
- Board-Certified, Family Medicine
- TMB License #T3117
- NPI: 1821613514
"Weight loss is a medical journey — and every patient deserves a physician who walks it with them, not just a subscription that ships a box."
Considering Other Options?
Your physician will help you choose the best medication for your goals. Here's how the other option compares.
Tirzepatide
Zepbound® / Mounjaro®
Dual-action GIP/GLP-1 therapy shown to produce up to 25% body weight loss. May be a better fit if you're looking for maximum weight loss potential.
Ready to Start Your Weight Loss Journey?
Book a consultation with Dr. Dean or Dr. Kline — most patients get started within 24 hours.
GLP-1 medications may cause serious side effects including risk of thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Compounded medications are not FDA-approved for safety, efficacy, or quality. Individual results may vary. Trinity Family Medicine provides telehealth services to patients who are physically located in Texas* at the time of service.